
London's stock market risks a major blow if AstraZeneca leaves, says report
AstraZeneca is reportedly weighing a move to shift its primary listing from London to the US, dealing a potential blow to the London Stock Exchange and the broader UK financial ecosystem, according to a CNBC report. Why it matters? AstraZeneca is the most …